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Abstract The microtubule-binding protein gephyrin is
known to play a pivotal role in targeting and clustering
postsynaptic inhibitory receptors. Here, the Intracellular
Antibodies Capture Technology (IATC) was used to select
two single-chain antibody fragments or intrabodies, which,
fused to nuclear localization signals (NLS), were able to
efficiently and selectively remove gephyrin from glycine
receptor (GlyR) clusters. Co-transfection of NLS-tagged
individual intrabodies with gephyrin-enhanced green fluo-
rescent protein (EGFP) in HEK 293 cells revealed a partial
relocalization of gephyrin aggregates onto the nucleus or in
the perinuclear area. When expressed in cultured neurons,
these intrabodies caused a significant reduction in the
number of immunoreactive GlyR clusters, which was
associated with a decrease in the peak amplitude of
glycine-evoked whole cell currents as assessed with
electrophysiological experiments. Hampering protein func-
tion at a posttranslational level may represent an attractive
alternative for interfering with gephyrin function in a more
spatially localized manner.
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Introduction
At inhibitory synapses, the microtubule-binding protein
gephyrin is known to play a pivotal role in targeting/
clustering postsynaptic inhibitory glycine receptors (GlyRs)
(Feng et al. 1998) and γ2-subunit containing gamma-
aminobutyric acid A (GABAA) receptors (Kneussel et al.
1999). Gephyrin binds with high affinity to the β subunit of
the GlyR (Meyer et al. 1995), whereas it only functionally
associates with GABAA receptor subtypes (Kirsch and Betz
1995; Meyer et al. 1995). Receptor anchoring is based on
the interaction of gephyrin with the actin- and microtubule-
based cytoskeleton (Kirsch 2006). GlyR clustering has been
proposed to rely on the ability of gephyrin to multimerize
into a submembraneous hexagonal protein lattice (Sola
et al. 2004). The critical contribution of gephyrin to the
postsynaptic localization of GlyRs in the spinal cord has
been elegantly demonstrated by gene ablation experiments
(Feng et al. 1998). Gephyrin knockout (KO) mice display a
severe neuromotor phenotype, which is responsible for their
death shortly after birth. The motor impairment observed in
gephyrin-deficient mice has been mainly attributed to a
J Mol Neurosci (2008) 34:141–148
DOI 10.1007/s12031-007-9018-6
Paola Zacchi, Elena Dreosti, and Michela Visintin contributed equally
to this work.
P. Zacchi (*):E. Dreosti: M. Moretto-Zita:I. Marchionni:
Z. Kasap: A. Cattaneo:E. Cherubini
Neuroscience Programme,
International School for Advanced Studies,
Via Beirut 2-4,
34014 Trieste, Italy
e-mail: zacchi@sissa.it
M. Visintin: I. Cannistraci: A. Cattaneo
Lay Line Genomics Spa,
Area Science Park,
34012 Basovizza, Trieste, Italy
H. Betz
Max-Planck Institute for Brain Research,
Deutschordenstrasse 46,
60528 Frankfurt am Main, Germany
Present address:
A. Cattaneo
European Brain Research Institute,
via del Fosso di Fiorano 64-65,
00143 Rome, Italysevere deficit in glycinergic neurotransmission in the spinal
cord (Feng et al. 1998). Interestingly, the complex motor
disorder and neurologic symptoms observed in gephyrin-
deficient mice exhibit some phenotypic features of hyper-
explexia in humans, suggesting the possible involvement of
gephyrin in this disease.
Gephyrin KO mice have been extremely useful for
unveiling several aspects of gephyrin-mediated receptor
localization at central synapses (Feng et al. 1998). How-
ever, the lethality exhibited by these mice soon after birth
represents an important limitation to their use as animal
models for postnatal studies. To circumvent this problem,
we have developed a more versatile and powerful molec-
ular tool to achieve functional ablation of gephyrin based
on intracellular expression of anti-gephyrin single-chain
antibody fragments (scFv) or intrabodies (Biocca et al.
1990). Unlike nucleic acid-based technologies, such as
antisense (Kramer and Cohen 2004), zinc-finger proteins
(Beerli and Barbas 2002), targeted gene disruption, or
(ribonucleic acid) RNA interference (Tian et al. 2004),
intrabodies operate at the posttranslational level, offering
new experimental opportunities to analyze the function of a
given molecule (Manikandan et al. 2007). Intrabodies can
sterically prevent the interaction of their targets with other
protein partners, or stabilize/destabilize them, thus prevent-
ing/facilitating their turnover and/or degradation. Finally,
intrabodies fused to specific cellular localization sequences
can target their antigens to specific subcellular compart-
ments (Visintin et al. 2004a).
In the present study, a nuclear localization signal (NLS)-
targeted intrabody for the removal of endogenous gephyrin
from inhibitory receptor clusters in cultured hippocampal
neurons has been developed. As not all antibodies isolated
by standard technologies fold well under conditions of
intracellular expression (Visintin et al. 2004a), we exploited
a yeast two-hybrid based intrabody selection technology,
named Intracellular Antibody Capture Technique (IACT)
(Visintin et al. 1999), to select anti-gephyrin intrabodies.
Material and Methods
SPLINT Selection
A Single Pot Library of INTrabodies (SPLINT) was used to
isolate antibodies against ghephyrin (aa 153–348) bait.
SPLINT contains genes encoding the heavy and light
variable regions of the antibody producing cells (Visintin
et al. 2004b). These are cloned in the IACT format as
antibody fragments (scFv) (Visintin et al. 1999). The library
design includes the capability to rapidly isolate soluble and
stable scFvs directly from gene sequences with no handling
of proteins.
A functional domain of the gephyrin protein (GDL aa
153–348) was cloned in the pMIC-BD1 vector and the
expression of the fusion protein was assayed after the
protein was extracted from the transformed yeast strain
L40. The antigen was found to be expressed in optimum
quantities in the yeast cells and did not transactivate the
reporter genes (HIS3 and lacZ).
SPLINT library was then transformed into L40 yeast
strain by using a rearranged lithium acetate transformation
protocol. SPLINT and the ghephyrin bait were cotrans-
formed into yeast cells as described (Visintin et al. 2002).
Colonies were isolated on histidine-deficient plates and
screened for β-gal activity on filters. Individual blue
colonies were isolated by restreaking and again reassayed
for β-gal activity. To isolate different anti-gephyrin scFvs,
a colony-polymerase chain reaction (PCR) and BstNI
fingerprinting analysis were performed and the isolated
plasmids encoding anti-gephyrin scFvs were individually
retested in a secondary IACT screening confirmed that
true positives were identified that interact specifically
with the original bait, but not with other lexA fusions
(lexA-lamin).
Cell Culture
Primary cell cultures were prepared as previously described
(Andjus et al. 1997). Briefly, 2- to 4-day-old (P2-P4) Wistar
rats were decapitated after being anesthetized with an
intraperitoneal injection of urethane (2 mg/kg). This
procedure is in accordance with the regulation of the Italian
Animal Welfare Act and was approved by the local
authority veterinary service. Hippocampus was dissected
free, sliced, and digested with trypsin, mechanically
triturated, centrifuged twice at 40×g. Dissociated neurons
were plated in Petri dishes, and cultured for up to 14 days.
Experiments were performed on cells cultured for at least
7 days. All the other cell lines used were routinely cultured
at 37°C in Dulbecco’s modified Eagle’s Medium (DMEM)
supplemented with 10% Fetal Bovine Serum (FBS)
Penicillin (100 U/ml) and Streptomycin (100 μg/ml).
Immunofluorescence Staining
HEK 293 cells were fixed with 4% (w/v) paraformalde-
hyde/4% sucrose for 15 min, permeabilized with 0.1% (v/v)
NP-40 for 5 min, and then blocked with 10% (w/v) fetal
bovine serum in phosphate-buffered saline (PBS) for
30 min. Hippocampal neurons were fixed for 10 min with
methanol at −20°C or for 15 minutes, and processed as
described above. Antibody staining was performed by
incubation for 1 hour with primary antibodies and 45 min
for secondary antibodies in blocking buffer. Enhanced
green fluorescent protein (EGFP) was visualized by auto-
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with the Meta-Morph Imaging System (Universal Imaging,
Westchester, PA). Twenty neurons were analyzed for each
experiment (3–4 dendritic regions for each cell).
Immunoprecipitation and Western Blot Analysis
Transfections were performed with the standard calcium
phosphate method. For gephyrin-EGFP and scFvGeph-2/
scFvGeph-9 coimmunoprecipitation HEK 293 cells over-
expressing gephyrin-EGFP and scFvGeph-2/scFvGeph-9
were lysed in a lysis buffer containing 50 mM Tris 7.5,
150 mM NaCl, 0.5% NP40, 2 mM ethylenediaminetetra-
acetic acid (EDTA) and 10% glycerol and immunoprecipi-
tated by the anti-SV5 antibody. Western blotting was
performed according to standard procedures. Primary anti-
bodies were revealed by HRPO-conjugated secondary
antibodies (SIGMA), followed by enhanced chemilumines-
cence (Amersham).
Electrophysiological Recordings
Glycine- and α-amino-3-hydroxy-5-methylisoxazole-4-
propionic acid (AMPA)-evoked currents were recorded at
room temperature (22–24°C) in the whole-cell configura-
tion of the patch-clamp technique using a Multiclamp 700A
(Axon Instruments, Foster City, CA, USA). Patch elec-
trodes, formed from thin borosilicate glass (Hilgenberg,
Malsfeld, Germany) had a resistance of 4–8M Ω when
filled with an intracellular solution containing: CsCl
137 mM, 4-2-hydroxyethyl-1-piperazineethanesulfonic acid
(HEPES) 10 mM, BAPTA 11 mM, MgCl2 2 mM, Mg ATP
2 mM, CaCl2 1 mM. The composition of the external
solution was: NaCl 137 mM, KCl 5 mM, MgCl2 1 mM,
CaCl2 2 mM, glucose 20 mM, hemisodium HEPES 10 mM
(the pH was adjusted to 7.3–7.4 with NaOH).
The stability of the patch was checked by repetitively
monitoring the input and series resistance during the
experiments. Cells exhibiting more than 15% changes were
excluded from the analysis. Glycine- and AMPA-evoked
currents were recorded at a holding potential of −40 mV.
Glycine and AMPA were applied through a multibarrel
RSC-200 perfusion system (Bio-logic, Grenoble, France).
With this system, a complete exchange of the solution
around the cell was obtained in less than 30 ms. In the case
of glycine-evoked current, recordings were routinely per-
formed in the presence of the GABAA receptor antagonist
picrotoxin (50 μM), the GABAB receptor antagonist CGP
55845 (1 μM) and the broad spectrum ionotropic glutamate
receptor antagonist kynurenic acid (1 mM).
Drugs used were kynurenic acid, glycine, AMPA,
strychnine all purchased from Sigma (Milan, Italy).
Picrotoxin and CGP 55845 were purchased from Tocris
Cookson, Ltd. (Bristol, UK). Drugs were dissolved in water
except CGP 55845 and picrotoxin that were dissolved in
dimethylsulphoxide (DMSO) and ethanol, respectively. The
final concentration of DMSO in the bathing solution was
0.1%. At this concentration, DMSO alone did not modify
the shape or the kinetics of the evoked currents. Currents
were sampled at 20–100 kHz and filtered with a cut-off
frequency of 1 kHz. Data are expressed as mean ± SEM.
Statistical comparison was made using the unpaired t-test.
P<0.05 was taken as significant.
Results
Selection of Two Gephyrin-Specific Intrabodies
Using the IAC Technology
To select intracellular competent intrabodies by the two-
hybrid system, the linker region of gephryin (Fig. 1a) was
cloned to the 3’ of LexA (LexA-GLD; aa 153–348) and
used to challenge a mouse SPLINT (Single Pot Library of
INTracellular Antibodies) library of intrabodies (Visintin
et al. 2004b). From the selection procedure a total of 90
colonies able to grow in the absence of histidine and
showing activation of β-Galactosidase were obtained. The
scFv-VP16 plasmids were isolated and sorted by their
restriction patterns and sequences. The specificity of scFvs
with different DNA fingerprints were reanalyzed using yeast
strains expressing LexA-GLD and LexA-lamin, as nonrel-
evant antigen. Two different anti-gephyrin scFvs, designated
scFvGeph-2 and scFvGeph-9, were thus identified. Analysis
of the V region nucleotide sequences of the two selected
anti-gephyrin intrabodies revealed that they were derived
from germline V region genes with very few somatic
mutations (data not shown). Both scFv shared the same
VH region V11 that belongs to the subgroup VH-VIII,
whereas VL regions belong to the kappa subgroup (kk4 and
19–32 for scFv2 and 9, respectively).
The selected intracellular antibodies were then expressed
in mammalian cells, after subcloning of the scFv cassettes
into the scFv-cyto-express plasmid (Persic et al. 1997).
For intracellular detection, scFvs were equipped with the
11 amino acid long SV5 tag, preceded, in the nuclear
tagged forms, by a tandem of three repeats of nuclear
localization signals (NLS). Extracts from HEK 293 cells
transiently transfected with scFvGeph-2 and scFvGeph-9
for different times demonstrated that the highest cytoplas-
mic expression was reached ∼24–30 hours posttransfection.
ScFvGeph-2 appeared to be more stable than scFvGeph-9,
yielding higher expression levels in mammalian cells as
compared to scFvGeph-9 (Fig. 1b). Similar results were
obtained for the intrabodies provided of the NLS (data not
shown).
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The ability of the selected intrabodies to recognize gephyrin
in mammalian cells was assessed in immunocytochemical
experiments performed on HEK 293 cells co-transfected
with scFvGeph-2/scFvGeph-9 and gephyrin fused to EGFP.
It is well-known that ectopically expressed gephyrin forms
large intracytoplasmic aggregates characterized by their
ability to actively sequester gephyrin interacting proteins
(Kins et al. 2000; Meyer et al. 1995). Intrabodies expressed
as leaderless cytoplasmic proteins showed a diffuse
intracellular staining, typical of soluble cytoplasmic pro-
teins (Fig. 2a). When gephyrin-EGFP and individual intra-
bodies were co-transfected, a massive fraction of
scFvGeph-2/scFvGeph-9 was relocalized to gephyrin intra-
cytoplasmic aggregates, thus resulting in colocalization of
the two proteins (Fig. 2a). When the same experiments
were performed using overexpression of the NLS-tagged
intrabodies, a dramatic change in gephyrin distribution was
observed (Fig. 2b). The efficient translocation of intra-
bodies into the nucleus because of the presence of the NLS
was associated with a partial reduction in the size of
gephyrin cytoplasmic aggregates, most of them concentrat-
ed in the perinuclear area of the cell. The ability of scFvs to
interact specifically with gephyrin was further analyzed by
co-immunoprecipitation from extracts of HEK 293 cells co-
expressing the two proteins. As shown in Fig. 2c,
scFvGeph-2/scFvGeph-9 antibodies were able to co-immu-
noprecipitate gephyrin, suggesting that they interacted with
gephyrin intracellularly.
Gephyrin-Specific Intrabodies Alter Endogenous Glycine
Receptor Function
The ability of the anti-gephyrin intrabodies to bind and
remove endogenous gephyrin from glycine receptor clusters
was functionally assessed on cultured hippocampal neu-
rons, known to highly express GlyRs (Danglot et al. 2004;
Ito and Cherubini 1991). To this aim, NLS-tagged
scFvGeph-2/ scFvGeph-9 were additionally equipped with
EGFP tags to easily follow their fate within the transfected
neurons. Twenty-four hours after transfection, immunocy-
tochemical experiments revealed that not only gephyrin was
Figure 1 Isolation and characterization of scFv selected by IACT-
SPLINT technology. a. The scFv library is screened in yeast with the
Gephyrin Linker Domain of (GLD) as a bait. Only those scFvs that
retain the specific binding ability in vivo can activate the reporter
genes, His3 and LacZ. b. Western immunoblot using mAb anti-SV5 of
cellular extracts of HEK 293 cells, transiently transfected with the
indicated scFvs tagged with SV5. On the left, soluble fraction of
scFvGeph-2 and scFvGeph-9 collected at different times after
transfection, as indicated (Hours). On the right, insoluble fractions
analyzed as in the right panel
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but also that the number of GlyR clusters were dramatically
reduced (Fig. 3b) compared to neurons transfected with
EGFP alone. A quantitative analysis of immunoreactive
gephyrin puncta in scFv-gephyrin-NLS transfected neurons
revealed that in comparison to cells transfected only with
EGFP, cluster fluorescence was significantly reduced.
Fluorescence intensity values per square micron (μm
2)o f
dendritic surface were 2,857±500 and 1,205±134 in
controls and scFv-gephyrin-NLS transfected cells, respec-
tively (20 cells, detected in four different experiments,
Fig. 3c). Similar results were found for GlyRs (fluorescence
intensity values per square micron of dendritic surface were
2,211±378 and 1,152±72 in controls and in scFv-gephyrin-
NLS transfected cells, respectively; n=20 in both cases;
Fig. 3c).
Glycine receptor responses in NLS-EGFP-tagged
scFvGeph-2 transfected neurons were analyzed in electro-
physiological experiments, using the whole-cell configura-
tion of the patch clamp technique. Recordings were routinely
performed in the presence of the GABAA receptor antago-
nist picrotoxin (50 μM), the GABAB receptor antagonist
CGP 55845 (1 μM), and the broad spectrum ionotropic
glutamate receptor antagonist kynurenic acid (1 mM). All
cells tested (n=99) responded to glycine application with
inward currents of variable amplitude. These were readily
blocked by the selective glycine receptor antagonist
strychnine (0.5 μM), indicating that they were mediated
by glycine receptors (data not shown). As shown in Fig. 4a,
glycine-evoked currents from transfected cells were signif-
icantly reduced in amplitude as compared to controls
(nontransfected cells from the same dish) or to hippocampal
neurons transfected only with EGFP. Glycine (0.6 mM)
induced current responses whose peak amplitude was 0.75±
0.11 nA (n=11), 1.52±0.12 nA (n=9), and 1.6±0.16 nA
(n=9) in NLS-scFvGeph-2, EGFP and nontransfected
cells, respectively. The value obtained in transfected cells
was significantly different from that detected in EGFP
positive cells (p<0.01) or in nontransfected neurons (p<
0.01). In comparison with nontransfected or EGFP-transfected
cells, NLS-scFvGeph-2-transfected neurons exhibited a
concentration–response curve for glycine that was com-
pressed downward and to the right (Fig. 4b). EC50 values
were 254 μM and 125 μM for NLS-scFvGeph-2- and
Figure 2 Gephyrin-specific
intrabodies interact with
gephyrin in mammalian cells.
a. Immunofluorescence assay of
the subcellular distribution of
SV5-tagged anti-gephyrin intra-
body (scFv-Gephyrin) ectopi-
cally expressed in HEK 293
cells in single transfection ex-
periment (left panel) and in
co-transfection with gephyrin-
EGFP (right panels). ScFv-
Gephyrin distribution was
revealed with the anti-SV5
monoclonal antibody followed
byanti-mouseTRITC-conjugated
secondary antibody. Gephyrin
distribution was revealed by the
intrinsic green fluorescence of
EGFP. b. Single (left panel) and
double (right panels) transfec-
tion of the nuclear target NLS
anti-Gephyrin intrabody (scFv-
Gephyrin-NLS) was visualized
as described in A. (Scale bar,
10 μm). c. Lysates of HEK 293
cells co-transfected with
gephyrin-FLAG and scFv-
Geph-2 or scFvGeph-9 were
immunoprecipitated with mono-
clonal antibodies anti-SV5
or anti-Myc as negative control.
Immunoprecipitates were ana-
lyzed by western blotting using
anti-FLAG and anti-SV5 anti-
bodies, as indicated
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responses elicited in the same neurons by α-amino-3-
hydroxy-5-methylisoxazole-4 propionic acid (AMPA
50 μM, in the presence of tetrodotoxin [TTX] 1 μM) were
similar in amplitude (0.20±0.03 nA, n=11 and 0.21±
0.02 nA, n=11, p>0.5; Fig. 4a) in both NLS-scFvGeph-2-
and EGFP-transfected cells, respectively, indicating that
gephyrin intrabodies selectively reduce surface glycine
receptor numbers.
Discussion
The main goal of the present study was to select competent
cytoplasmic intrabodies against the scaffolding molecule
gephyrin to use as a molecular tool to knock out gephyrin
function in vivo. This strategy is of particular relevance as
disrupting gephyrin gene in knockout mice leads to a lethal
phenotype, thus hindering the study of gephyrin functions
at later stages of postnatal development. To exploit the
intrabodies-based retargeting scheme for depleting endog-
enous gephyrin from inhibitory synapses, the linker or
intervening region of gephyrin molecule was used for the
two-hybrid selection method. This domain was chosen as it
is not engaged in gephyrin oligomerization, a process
regarded as the molecular mechanism responsible for
inhibitory receptors accumulation at postsynaptic sites (Sola
et al. 2004). As a consequence, the selected intrabodies
should recognize gephyrin upon its self-assembly into the
submembraneous protein lattice underlying inhibitory re-
ceptor clusters. Several lines of evidence support that the
selected intrabodies are fully functional inside the cell.
First, both intrabodies immunoprecipitate gephyrin upon
their co-expression in HEK 293 cells. Second, they are
specifically relocalized to gephyrin cytoplasmic aggregates.
Interestingly, in the NLS-tagged format to divert intrabodies
localization, they were able to promote a partial relocaliza-
tion of gephyrin aggregates into the nucleus. We believe
Figure 3 ScFv-Geph2-EGFP-NLS transfected in hippocampal neu-
rons displaces gephyrin from its subsynaptic sites. A, B. Hippocampal
neurons transfected with EGFP as negative control (EGFP) and with
scFv-Geph-2-EGFP-NLS (scFv-Geohyrin). Endogenous gephyrin (a)
and GlyR (b) distributions were revealed using the monoclonal
antibodies mAb7a (for gephyrin) and mAb4a (for GlyR) followed by
anti-mouse TRITC-conjugated secondary antibody (Invitrogen). Note
that the nuclear accumulation of scFv-Gephyrin-NLS was associated
with a marked reduction of both gephyrin (scFv + Gephyrin in A) and
glycine receptor clusters (scFv + GlyRs in B). Bottom panels represent
enlargements of the boxed areas. Scale bars: 10 μm. c. Quantitative
analysis of cluster fluorescence on hippocampal neurons transfected
with EGFP and scFv-Gephyrin-NLS. Each column represents the
intensity signal normalized to the unit area (in μm
2) of dendritic
surface (20 cells in each column) in control conditions (black) and in
the presence of scFv-Gephyrin-NLS (white); * p<0.05
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aggregates into the nucleus is probably caused by their
size—too big to allow nuclear pore crossing. Finally, and
most importantly, when ectopically expressed in cultured
hippocampal neurons, both selected intrabodies were able
to remove endogenous gephyrin from GlyRs clusters,
leading to a decreased number of GlyR immunoreactive
punctae associated with a severe reduction in the mean
amplitude of glycine-evoked currents.
Certainly, alternative strategies can be used to target and
inactivate intracellular proteins. One of the most currently
used is the RNA interference (RNAi), which acts at the
level of mRNA degradation and subsequent inhibition of
protein synthesis. However, major technical challenges of
this technique are the specificity of sequence match
necessary to achieve gene silencing and the nonspecific
effects of small interfering RNAs (siRNA). Concerning the
latter, microarray analyses have demonstrated that siRNA
with only partial complementarity to mRNAs can cause a
reduction in the RNA levels of a large number of transcripts
(Jackson et al. 2003). Many of these mRNA changes are
caused by the interaction of the siRNA with partially
complementary sites and thus are considered "off-target"
effects (Birmingham et al. 2006; Saxena et al. 2003).
Another major deficiency of utilizing siRNAs is their
relatively short active half-life, which would limit their
effects on the cell, unless these are expressed via trans-
fected recombinant DNA. By contrast, intrabodies possess
a much longer active half-life compared to siRNA, and are
also much more specific to their target molecules (Visintin
et al. 2004a). Therefore, it would be particularly advanta-
geous to utilize an intrabody instead of iRNA when the
active half-life of the target molecule is long, as in the case
of neuronal gephyrin. In addition, in the case of proteins
with multifunctional domains, intrabodies could be
designed to block selectively a particular binding interac-
tion domain therefore leading to the loss of a certain
function while sparing others.
Hampering protein function at the posttranslational level
may have distinctive advantages, especially when dealing
with cells with complex and spatially extended morpholo-
gy, such as nerve cells, where functional knock-down with
intrabodies could be achieved in a more spatially localized
manner, or where one could target subcellular pools of a
given target protein. The recombinant antibody we selected
could be exploited for developing conditional transgenic
mice where scFv expression is under the control of a
neuronal cell type specific (tissue-specific) promoter.
Alternatively, viral expression vectors may be used to
transduce gephyrin-specific intrabodies in nondividing
neuronal populations in specific areas of the CNS, giving
the possibility to follow the consequences of gephyrin
expression and its functional ablation within the same
biological preparation. In particular, the occurrence in the
same neuronal tissue of cells phenotypically knocked out
for gephyrin with WT ones may allow studying the
mechanisms regulating neurotransmitter receptor move-
ments on the cell surface and the contribution of receptor
clustering to the cross talk between pre and postsynaptic
membranes.
Figure 4 AMPA and glycine evoked currents on hippocampal
neurons transfected with ScFv-Geph2-EGFP-NLS a. Upper traces:
current responses evoked at −40 mV by application of AMPA
(50 μM; open bars) in nontransfected (left) and scFv-Gephyrin-NLS
transfected neurons present in the same dish (right). Lower traces:
current responses evoked at −40 mV by application of glycine
(100 μM; closed bars) in nontransfected (left) and scFv-Gephyrin-
NLS transfected neurons present in the same dish (right). b. Dose–
response curves for glycine-evoked currents obtained in hippocampal
neurons transfected with EGFP (open triangles) or with scFv-
Gephyrin-NLS (scFv-Gephyrin, closed triangles). Open circles refer
to current responses obtained from nontransfected cells present with
scFv-Gephyrin-NLS transfected neurons on the same dish. Each point
is the average of 9–20 individual responses
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